464 related articles for article (PubMed ID: 27155373)
1. Could drugs inhibiting the mevalonate pathway also target cancer stem cells?
Likus W; Siemianowicz K; Bieńk K; Pakuła M; Pathak H; Dutta C; Wang Q; Shojaei S; Assaraf YG; Ghavami S; Cieślar-Pobuda A; Łos MJ
Drug Resist Updat; 2016 Mar; 25():13-25. PubMed ID: 27155373
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol and beyond - The role of the mevalonate pathway in cancer biology.
Göbel A; Rauner M; Hofbauer LC; Rachner TD
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188351. PubMed ID: 32007596
[TBL] [Abstract][Full Text] [Related]
3. The balance between induction and inhibition of mevalonate pathway regulates cancer suppression by statins: A review of molecular mechanisms.
Ahmadi Y; Ghorbanihaghjo A; Argani H
Chem Biol Interact; 2017 Aug; 273():273-285. PubMed ID: 28668359
[TBL] [Abstract][Full Text] [Related]
4. Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.
Mokarram P; Alizadeh J; Razban V; Barazeh M; Solomon C; Kavousipour S
Curr Mol Pharmacol; 2017; 10(2):86-114. PubMed ID: 26758947
[TBL] [Abstract][Full Text] [Related]
5. Bergamot natural products eradicate cancer stem cells (CSCs) by targeting mevalonate, Rho-GDI-signalling and mitochondrial metabolism.
Fiorillo M; Peiris-Pagès M; Sanchez-Alvarez R; Bartella L; Di Donna L; Dolce V; Sindona G; Sotgia F; Cappello AR; Lisanti MP
Biochim Biophys Acta Bioenerg; 2018 Sep; 1859(9):984-996. PubMed ID: 29626418
[TBL] [Abstract][Full Text] [Related]
6. Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease.
Hashemi M; Hoshyar R; Ande SR; Chen QM; Solomon C; Zuse A; Naderi M
Curr Mol Pharmacol; 2017; 10(1):13-26. PubMed ID: 26758949
[TBL] [Abstract][Full Text] [Related]
7. Novel prospects of statins as therapeutic agents in cancer.
Pisanti S; Picardi P; Ciaglia E; D'Alessandro A; Bifulco M
Pharmacol Res; 2014 Oct; 88():84-98. PubMed ID: 25009097
[TBL] [Abstract][Full Text] [Related]
8. Key roles of Rho GTPases, YAP, and Mutant P53 in anti-neoplastic effects of statins.
Ji L; Liu C; Yuan Y; Gao H; Tang ZX; Yang Z; Liu ZT; Jiang GH
Fundam Clin Pharmacol; 2020 Feb; 34(1):4-10. PubMed ID: 31241783
[TBL] [Abstract][Full Text] [Related]
9. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.
Yeganeh B; Wiechec E; Ande SR; Sharma P; Moghadam AR; Post M; Freed DH; Hashemi M; Shojaei S; Zeki AA; Ghavami S
Pharmacol Ther; 2014 Jul; 143(1):87-110. PubMed ID: 24582968
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Mevalonate Pathway for Treating Esophageal Cancer.
Wong JVS; Fatehi Hassanabad A
J Gastrointest Cancer; 2021 Jun; 52(2):819-821. PubMed ID: 33931828
[TBL] [Abstract][Full Text] [Related]
11. Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins.
Iannelli F; Lombardi R; Milone MR; Pucci B; De Rienzo S; Budillon A; Bruzzese F
Recent Pat Anticancer Drug Discov; 2018; 13(2):184-200. PubMed ID: 29189178
[TBL] [Abstract][Full Text] [Related]
12. Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines.
Palozza P; Colangelo M; Simone R; Catalano A; Boninsegna A; Lanza P; Monego G; Ranelletti FO
Carcinogenesis; 2010 Oct; 31(10):1813-21. PubMed ID: 20699249
[TBL] [Abstract][Full Text] [Related]
13. Mevalonate Pathway and Human Cancers.
Bathaie SZ; Ashrafi M; Azizian M; Tamanoi F
Curr Mol Pharmacol; 2017; 10(2):77-85. PubMed ID: 26758953
[TBL] [Abstract][Full Text] [Related]
14. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
[TBL] [Abstract][Full Text] [Related]
15. The Mevalonate Pathway and Innate Immune Hyper-Responsiveness in the Pathogenesis of COPD and Lung Cancer: Potential for Chemoprevention.
Young RP; Hopkins RJ
Curr Mol Pharmacol; 2017; 10(1):46-59. PubMed ID: 26758944
[TBL] [Abstract][Full Text] [Related]
16. Statins and protein prenylation in cancer cell biology and therapy.
Garcia-Ruiz C; Morales A; Fernandez-Checa JC
Anticancer Agents Med Chem; 2012 May; 12(4):303-15. PubMed ID: 22413970
[TBL] [Abstract][Full Text] [Related]
17. The role of statins as therapeutic agents in cancer.
Sopková J; Vidomanová E; Strnádel J; Škovierová H; Halašová E
Gen Physiol Biophys; 2017 Dec; 36(5):501-511. PubMed ID: 29372683
[TBL] [Abstract][Full Text] [Related]
18. Basic and Clinical Observations of Mevalonate Depletion on the Mevalonate Signaling Pathway.
Muller AL; Freed DH
Curr Mol Pharmacol; 2017; 10(1):6-12. PubMed ID: 26758946
[TBL] [Abstract][Full Text] [Related]
19. Statins, stem cells, and cancer.
Gauthaman K; Fong CY; Bongso A
J Cell Biochem; 2009 Apr; 106(6):975-83. PubMed ID: 19224538
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin interferes with cancer 'stem-cell' plasticity reducing metastasis in ovarian cancer.
Kato S; Liberona MF; Cerda-Infante J; Sánchez M; Henríquez J; Bizama C; Bravo ML; Gonzalez P; Gejman R; Brañes J; García K; Ibañez C; Owen GI; Roa JC; Montecinos V; Cuello MA
Endocr Relat Cancer; 2018 Oct; 25(10):821-836. PubMed ID: 29848667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
